Bovine Pili Shield+C

This page contains information on Bovine Pili Shield+C for veterinary use.
The information provided typically includes the following:

Bovine Pili Shield+C Indications
Warnings and cautions for Bovine Pili Shield+C
Direction and dosage information for Bovine Pili Shield+C

Bovine Pili Shield+c

This treatment applies to the following species:

Manufacturer: Novartis (Farm Animal)

Clostridium Perfringens Type C-escherichia Coli Bacterin-toxoid

For Use In Animals Only

Bovine Pili Shield+C Indications

For use in healthy pregnant cattle as an aid in the prevention of enterotoxemia in calves caused by Clostridium perfringens Type C and colibacillosis in calves caused by K99 piliated Escherichia coli.

Adjuvant

Xtend^® III.

Directions

Shake well before using. Administer 1 mL intramuscularly in the neck 8-16 weeks prior to calving. Vaccinate dairy cows at dry-off. Revaccinate prior to each subsequent calving.

Precautions

Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. It is essential that newborn calves receive colostrum from the vaccinated dam. WARNING: THIS PRODUCT MAY CAUSE PERSISTENT SWELLING AT THE SITE OF INJECTION. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.

20 Doses	20 mL	246-01
100 Doses	100 mL	247-01

Nac No.

11140065

NOVARTIS ANIMAL HEALTH US, INC.
Farm Animal Business
1447 140TH ST., LARCHWOOD, IA, 51241

Telephone:		712-477-2811
Order Desk:		800-843-3386
Fax:		712-477-2686
Technical Information:		800-843-3386
Website:		www.livestock.novartis.com
Email (Product Services):		leann.schulz@novartis.com

Every effort has been made to ensure the accuracy of the Bovine Pili Shield+C information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Printable Version

Email Page